Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126987171 | 12698717 | 1 | I | 20150921 | 20160815 | 20160830 | 20160830 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01668 | WESTWARD | 34.36 | YR | M | Y | 0.00000 | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126987171 | 12698717 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | Unknown | Y | 71471 | ||||||||||
| 126987171 | 12698717 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | Y | 71471 | |||||||||||
| 126987171 | 12698717 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | Y | 71471 | ||||||||||
| 126987171 | 12698717 | 4 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | Y | 71471 | ||||||||||
| 126987171 | 12698717 | 5 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | Y | 71471 | ||||||||||
| 126987171 | 12698717 | 6 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | Y | 71471 | ||||||||||
| 126987171 | 12698717 | 7 | SS | IDARUBICIN | IDARUBICIN | 1 | Unknown | 65275 | |||||||||||
| 126987171 | 12698717 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | BID | ||||||||
| 126987171 | 12698717 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 0 | |||||||||||
| 126987171 | 12698717 | 10 | C | FORMOTEROL-MOMETASONE | 2 | 0 | |||||||||||||
| 126987171 | 12698717 | 11 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | 90 | UG | QID | |||||||||
| 126987171 | 12698717 | 12 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126987171 | 12698717 | 13 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 0 | 37.5 | MG | BID | ||||||||
| 126987171 | 12698717 | 14 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | 25 | MG | BID | ||||||||
| 126987171 | 12698717 | 15 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 126987171 | 12698717 | 16 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | |||||||||||
| 126987171 | 12698717 | 17 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | 0 | 5 | MG | |||||||||
| 126987171 | 12698717 | 18 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TID | ||||||||
| 126987171 | 12698717 | 19 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 0 | 500 | MG | BID | ||||||||
| 126987171 | 12698717 | 20 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Oral | 0 | 750 | MG | BID | ||||||||
| 126987171 | 12698717 | 21 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 126987171 | 12698717 | 22 | C | OXYCODONE | OXYCODONE | 1 | Unknown | 0 | |||||||||||
| 126987171 | 12698717 | 23 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 100 | MG | TID | ||||||||
| 126987171 | 12698717 | 24 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 126987171 | 12698717 | 25 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | |||||||||||
| 126987171 | 12698717 | 26 | C | CLARITIN | LORATADINE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126987171 | 12698717 | 27 | C | LORATADINE. | LORATADINE | 1 | Unknown | 0 | |||||||||||
| 126987171 | 12698717 | 28 | C | COLLAGENASE SANTYL | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 1 | Unknown | 0 | |||||||||||
| 126987171 | 12698717 | 29 | C | VIGILON | 2 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126987171 | 12698717 | 1 | Acute myeloid leukaemia |
| 126987171 | 12698717 | 7 | Acute myeloid leukaemia |
| 126987171 | 12698717 | 8 | Type 2 diabetes mellitus |
| 126987171 | 12698717 | 9 | Type 2 diabetes mellitus |
| 126987171 | 12698717 | 10 | Asthma |
| 126987171 | 12698717 | 11 | Asthma |
| 126987171 | 12698717 | 12 | Hypertension |
| 126987171 | 12698717 | 13 | Hypertension |
| 126987171 | 12698717 | 15 | Hypertension |
| 126987171 | 12698717 | 16 | Hypertension |
| 126987171 | 12698717 | 17 | Hypertension |
| 126987171 | 12698717 | 19 | Seizure |
| 126987171 | 12698717 | 21 | Headache |
| 126987171 | 12698717 | 22 | Headache |
| 126987171 | 12698717 | 23 | Product used for unknown indication |
| 126987171 | 12698717 | 24 | Ischaemic stroke |
| 126987171 | 12698717 | 25 | Ischaemic stroke |
| 126987171 | 12698717 | 26 | Product used for unknown indication |
| 126987171 | 12698717 | 27 | Product used for unknown indication |
| 126987171 | 12698717 | 28 | Limb injury |
| 126987171 | 12698717 | 29 | Limb injury |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126987171 | 12698717 | HO |
| 126987171 | 12698717 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126987171 | 12698717 | Clostridium difficile colitis | |
| 126987171 | 12698717 | Deep vein thrombosis | |
| 126987171 | 12698717 | Escherichia bacteraemia | Escherichia bacteraemia |
| 126987171 | 12698717 | Escherichia sepsis | |
| 126987171 | 12698717 | Febrile neutropenia | |
| 126987171 | 12698717 | Mucosal inflammation | |
| 126987171 | 12698717 | Pulmonary mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126987171 | 12698717 | 1 | 20150910 | 0 | ||
| 126987171 | 12698717 | 2 | 20150926 | 0 | ||
| 126987171 | 12698717 | 3 | 20151119 | 20151124 | 0 | |
| 126987171 | 12698717 | 4 | 20151230 | 20160104 | 0 | |
| 126987171 | 12698717 | 5 | 20160211 | 20160216 | 0 | |
| 126987171 | 12698717 | 6 | 20160316 | 20160321 | 0 | |
| 126987171 | 12698717 | 7 | 20150910 | 0 |